Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$352,772,000
-$58,600,000 QoQ
Shares Held
14,650,000
0.0% QoQ
Ownership
0.257%
of shares outstanding
% of Portfolio
3.01%
of 13F equity value
Holder Rank
#42
of 2,816 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Unisphere Establishment holds $361,767,725 across 2 Drug Manufacturers - General names. PFE ranks #1 (97.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
This page
|
14,650,000 | $352,772,000 | |
| 2 | LLY |
ELI LILLY & Co
|
7,500 | $8,995,725 |
All Filings in PFE
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $352,772,000 | 14,650,000 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $411,372,000 | 14,650,000 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $364,785,000 | 14,650,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $366,912,000 | 14,400,000 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $306,636,000 | 12,650,000 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $320,551,000 | 12,650,000 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $335,604,500 | 12,650,000 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $366,091,000 | 12,650,000 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $353,947,000 | 12,650,000 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $351,037,500 | 12,650,000 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $331,804,750 | 11,525,000 | Shares | Defined | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||